141 related articles for article (PubMed ID: 2981982)
61. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.
Allan SG; Gregor A; Cornbleet MA; Leonard RC; Smyth JF; Grant IW; Crompton GK
Cancer Chemother Pharmacol; 1984; 13(2):106-8. PubMed ID: 6205780
[TBL] [Abstract][Full Text] [Related]
62. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685
[TBL] [Abstract][Full Text] [Related]
63. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
64. [Phase III therapy study in patients with small cell bronchial cancer].
Zschaber R; Gatzemeier U; Koschel G; Kaukel E; Heilmann HP; Hossfeld DK
Onkologie; 1988; 11 Suppl 2():9-12. PubMed ID: 2851762
[TBL] [Abstract][Full Text] [Related]
65. Chemotherapy of non-small-cell lung cancer.
Klastersky J; Sculier JP
Semin Oncol; 1985 Dec; 12(4 Suppl 6):38-48. PubMed ID: 3936181
[TBL] [Abstract][Full Text] [Related]
66. Etoposide v etoposide and cisplatin in the treatment of advanced non-small cell lung cancer: a FONICAP randomized study.
Rosso R; Ardizzoni A; Salvati F; Gallo-Curcio C; Rubagotti A; Fusco V; Brunetti I; DePalma M; Crucsiani AR; Portalone L
Semin Oncol; 1988 Dec; 15(6 Suppl 7):49-51. PubMed ID: 2851179
[TBL] [Abstract][Full Text] [Related]
67. Management of non-small-cell cancer.
Soukop M
Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364
[No Abstract] [Full Text] [Related]
68. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.
Van Houtte P; Klastersky J; Renaud A; Michel J; Vandermoten G; Nguyen H; Sculier JP; Devriendt J; Mommen P
Antibiot Chemother (1971); 1988; 41():131-7. PubMed ID: 2854432
[No Abstract] [Full Text] [Related]
69. Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Muggia FM; Blum RH; Foreman JD
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):137-45. PubMed ID: 6365863
[TBL] [Abstract][Full Text] [Related]
70. Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
Joss RA; Obrecht JP; Jungi WF; Alberto P; Sauter C; Cavalli F
Cancer Chemother Pharmacol; 1984; 13(2):148-9. PubMed ID: 6088102
[TBL] [Abstract][Full Text] [Related]
71. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Kelsen DP; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
Cancer; 1982 Mar; 49(6):1174-7. PubMed ID: 6174199
[TBL] [Abstract][Full Text] [Related]
72. Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs.
Sørensen JB; Hansen HH; Dombernowsky P; Bork E; Malmberg R; Aabo K; Bødker B; Hansen M
J Clin Oncol; 1987 Aug; 5(8):1169-77. PubMed ID: 3040918
[TBL] [Abstract][Full Text] [Related]
73. Two randomized trials for alternating polychemotherapy of small cell lung cancer.
Havemann K; Gropp C; Klapsing J; Viktor N; Holle R; Drings P; Manke HG; Hans K; Schroeder M; Heim M
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S40-4. PubMed ID: 3028663
[TBL] [Abstract][Full Text] [Related]
74. Chemotherapy for advanced adenocarcinoma of the lung: the Copenhagen study and review of the literature.
Sørensen JB
Semin Oncol; 1988 Dec; 15(6 Suppl 7):56-7. PubMed ID: 3217807
[TBL] [Abstract][Full Text] [Related]
75. Combination chemotherapy for advanced adenocarcinoma of the lung. A review.
Sørensen JB; Hansen HH
Cancer Chemother Pharmacol; 1988; 21(2):103-16. PubMed ID: 3280152
[TBL] [Abstract][Full Text] [Related]
76. Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Hirosawa A; Niitani H; Hayashibara K; Tsuboi E
Cancer Chemother Pharmacol; 1989; 23(4):255-8. PubMed ID: 2538252
[TBL] [Abstract][Full Text] [Related]
77. VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group Study.
Vaughn CB; Green SJ; O'Bryan R; Reed M; Grozea PN; Fletcher WS; Green JB; Metch B; Oishi N
Med Pediatr Oncol; 1988; 16(5):312-9. PubMed ID: 3054453
[TBL] [Abstract][Full Text] [Related]
78. Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapy.
Bedikian AY; Patt YZ; Murphy WK; Umsawasadi T; Carr DT; Hersh EM; Bodey GP; Valdivieso M
Am J Clin Oncol; 1984 Oct; 7(5):399-404. PubMed ID: 6391140
[TBL] [Abstract][Full Text] [Related]
79. Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
Ferrazzi E; Zagonel V; Vinante O; Galligioni E; Pappagallo GL; Cartei G; Fiorentino MV
Tumori; 1982 Dec; 68(6):531-5. PubMed ID: 6301122
[TBL] [Abstract][Full Text] [Related]
80. cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancer.
Carmichael J; Gregor A; Cornbleet MA; Allan SG; McIntyre MA; Grant IW; Compton GK; Leonard RC; Smyth JF
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):811-4. PubMed ID: 4043170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
